| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.724 | 0.008 | 0.724 | Aryl hydrocarbon receptor agonist | 0.645 0.012 CID_215925 | ||
| 0.531 | 0.022 | 0.548 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.548 0.017 CID_215925 | CID_215925 | |
| 0.497 | 0.027 | 0.497 | GABA C receptor rho-3 antagonist | 0.299 0.116 CID_215925 | ||
| 0.457 | 0.018 | 0.457 | Superoxide dismutase inhibitor | 0.341 0.038 CID_215925 | ||
| 0.448 | 0.014 | 0.448 | Peroxidase inhibitor | 0.26 0.045 CID_215925 | ||
| 0.461 | 0.038 | 0.478 | Angiogenesis inhibitor | 0.478 0.034 CID_215925 | CID_215925 | |
| 0.407 | 0.025 | 0.407 | Dyrk kinase inhibitor | 0.296 0.054 CID_215925 | ||
| 0.397 | 0.025 | 0.397 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.29 0.053 CID_215925 | ||
| 0.45 | 0.078 | 0.45 | MAP kinase 1 inhibitor | 0.437 0.084 CID_215925 | ||
| 0.368 | 0.007 | 0.368 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.283 0.013 CID_215925 | ||
| 0.367 | 0.007 | 0.367 | Abl kinase inhibitor | 0.282 0.013 CID_215925 | ||
| 0.375 | 0.015 | 0.375 | MAP kinase kinase 2 inhibitor | 0.271 0.045 CID_215925 | ||
| 0.369 | 0.012 | 0.369 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.311 0.023 CID_215925 | ||
| 0.421 | 0.066 | 0.478 | 5 Hydroxytryptamine release inhibitor | 0.478 0.04 CID_215925 | CID_215925 | |
| 0.34 | 0.005 | 0.34 | Nitric-oxide synthase stimulant | 0.289 0.014 CID_215925 | ||
| 0.352 | 0.017 | 0.352 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.293 0.029 CID_215925 | ||
| 0.352 | 0.02 | 0.352 | CDC-like kinase 2 inhibitor | 0.28 0.036 CID_215925 | ||
| 0.353 | 0.025 | 0.353 | Death-associated protein kinase 3 inhibitor | 0.296 0.039 CID_215925 | ||
| 0.343 | 0.017 | 0.343 | TRKC antagonist | 0.252 0.047 CID_215925 | ||
| 0.322 | 0.005 | 0.322 | MAP kinase kinase 3 inhibitor | 0.252 0.03 CID_215925 | ||
| 0.381 | 0.07 | 0.381 | MAP kinase kinase 6 inhibitor | 0.246 0.196 CID_215925 | ||
| 0.319 | 0.009 | 0.339 | Hexokinase inhibitor | 0.339 0.007 CID_215925 | CID_215925 | |
| 0.308 | 0.003 | 0.308 | Toll-Like receptor 3 antagonist | 0.175 0.009 CID_215925 | ||
| 0.327 | 0.025 | 0.327 | CDC-like kinase 4 inhibitor | 0.235 0.052 CID_215925 | ||
| 0.328 | 0.032 | 0.328 | Clk dual-specificity kinase inhibitor | 0.226 0.065 CID_215925 | ||
| 0.307 | 0.014 | 0.324 | Growth factor agonist | 0.324 0.011 CID_215925 | CID_215925 | |
| 0.324 | 0.03 | 0.324 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.17 0.078 CID_215925 | ||
| 0.306 | 0.017 | 0.306 | Protein kinase (CK1) inhibitor | 0.182 0.047 CID_215925 | ||
| 0.304 | 0.014 | 0.304 | Focal adhesion kinase 2 inhibitor | 0.273 0.026 CID_215925 | ||
| 0.305 | 0.016 | 0.305 | Protein kinase (CK1) gamma 3 inhibitor | 0.196 0.049 CID_215925 | ||
| 0.308 | 0.019 | 0.308 | LIM domain kinase 1 inhibitor | 0.252 0.037 CID_215925 | ||
| 0.302 | 0.014 | 0.302 | I kappa B kinase epsilon inhibitor | 0.227 0.051 CID_215925 | ||
| 0.306 | 0.019 | 0.306 | Protein kinase (CK1) gamma 1 inhibitor | 0.213 0.038 CID_215925 | ||
| 0.299 | 0.024 | 0.299 | Protein kinase C nu inhibitor | 0.195 0.049 CID_215925 | ||
| 0.281 | 0.01 | 0.281 | Cyclin-dependent kinase 8 inhibitor | 0.255 0.015 CID_215925 | ||
| 0.291 | 0.02 | 0.291 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.17 0.056 CID_215925 | ||
| 0.31 | 0.04 | 0.31 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.167 0.098 CID_215925 | ||
| 0.299 | 0.031 | 0.299 | MAP-kinase-activated kinase 5 inhibitor | 0.213 0.088 CID_215925 | ||
| 0.36 | 0.093 | 0.36 | 15-Lipoxygenase inhibitor | 0.268 0.151 CID_215925 | ||
| 0.279 | 0.015 | 0.279 | TRKA antagonist | 0.169 0.04 CID_215925 | ||
| 0.27 | 0.008 | 0.27 | MAP kinase kinase kinase inhibitor | 0.235 0.012 CID_215925 | ||
| 0.297 | 0.037 | 0.297 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.188 0.086 CID_215925 | ||
| 0.278 | 0.023 | 0.278 | Protein kinase (CK1) gamma inhibitor | 0.179 0.053 CID_215925 | ||
| 0.276 | 0.02 | 0.276 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.201 0.042 CID_215925 | ||
| 0.266 | 0.013 | 0.266 | Cyclin-dependent kinase 9 inhibitor | 0.167 0.029 CID_215925 | ||
| 0.264 | 0.015 | 0.264 | Protein kinase (CK1) delta inhibitor | 0.185 0.034 CID_215925 | ||
| 0.266 | 0.023 | 0.266 | Tyrosine-protein kinase receptor antagonist | 0.175 0.052 CID_215925 | ||
| 0.292 | 0.05 | 0.292 | Pyruvate kinase inhibitor | 0.239 0.065 CID_215925 | ||
| 0.259 | 0.019 | 0.259 | Cyclin-dependent kinase 7 inhibitor | 0.221 0.027 CID_215925 | ||
| 0.259 | 0.023 | 0.259 | Histone acetyltransferase inhibitor | 0.202 0.066 CID_215925 | ||
| 0.28 | 0.044 | 0.306 | 5 Hydroxytryptamine 1E antagonist | 0.306 0.026 CID_215925 | CID_215925 | |
| 0.251 | 0.016 | 0.251 | MAP kinase 9 inhibitor | 0.147 0.039 CID_215925 | ||
| 0.259 | 0.024 | 0.259 | Glycogen synthase kinase-3 alpha inhibitor | 0.19 0.044 CID_215925 | ||
| 0.365 | 0.134 | 0.49 | Caspase 9 stimulant | 0.49 0.064 CID_215925 | CID_215925 | |
| 0.27 | 0.041 | 0.27 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.218 0.059 CID_215925 | ||
| 0.272 | 0.049 | 0.272 | Tyrosine kinase inhibitor | 0.174 0.078 CID_215925 | ||
| 0.259 | 0.044 | 0.259 | RNA-directed DNA polymerase inhibitor | 0.181 0.131 CID_215925 | ||
| 0.219 | 0.007 | 0.219 | Pim-3 kinase inhibitor | 0.111 0.036 CID_215925 | ||
| 0.235 | 0.025 | 0.235 | Ribosomal protein S6 kinase inhibitor | 0.131 0.08 CID_215925 | ||
| 0.225 | 0.027 | 0.225 | Activin receptor-like kinase 2 inhibitor | 0.144 0.072 CID_215925 | ||
| 0.225 | 0.029 | 0.225 | Interleukin 6 antagonist | |||
| 0.217 | 0.023 | 0.217 | Vascular endothelial growth factor 1 antagonist | 0.127 0.051 CID_215925 | ||
| 0.203 | 0.01 | 0.215 | Bcr-Abl kinase inhibitor | 0.215 0.009 CID_215925 | CID_215925 | |
| 0.209 | 0.019 | 0.209 | MAP kinase 13 inhibitor | 0.14 0.041 CID_215925 | ||
| 0.242 | 0.056 | 0.287 | Peptidyltransferase inhibitor | 0.287 0.03 CID_215925 | CID_215925 | |
| 0.218 | 0.034 | 0.218 | Vascular endothelial growth factor antagonist | 0.169 0.048 CID_215925 | ||
| 0.265 | 0.083 | 0.294 | Insulysin inhibitor | 0.294 0.062 CID_215925 | CID_215925 | |
| 0.214 | 0.034 | 0.214 | Cyclin-dependent kinase inhibitor | 0.174 0.046 CID_215925 | ||
| 0.189 | 0.009 | 0.19 | Interleukin 2 antagonist | 0.19 0.009 CID_215925 | CID_215925 | |
| 0.214 | 0.038 | 0.214 | Polo-like kinase-3 inhibitor | 0.158 0.076 CID_215925 | ||
| 0.229 | 0.053 | 0.229 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.183 0.09 CID_215925 | ||
| 0.185 | 0.011 | 0.185 | MAP kinase 11 inhibitor | 0.114 0.028 CID_215925 | ||
| 0.208 | 0.034 | 0.211 | Cytokine production inhibitor | 0.211 0.033 CID_215925 | CID_215925 | |
| 0.201 | 0.028 | 0.201 | MAP kinase kinase inhibitor | 0.124 0.07 CID_215925 | ||
| 0.318 | 0.145 | 0.432 | Transcription factor inhibitor | 0.432 0.098 CID_215925 | CID_215925 | |
| 0.265 | 0.093 | 0.265 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.197 0.161 CID_215925 | ||
| 0.201 | 0.032 | 0.201 | Protein kinase (CK1) gamma 2 inhibitor | 0.106 0.077 CID_215925 | ||
| 0.232 | 0.062 | 0.232 | ErbB-1 antagonist | |||
| 0.201 | 0.033 | 0.245 | Cyclin-dependent kinase 3 inhibitor | 0.245 0.017 CID_215925 | CID_215925 | |
| 0.172 | 0.004 | 0.172 | Glutamate (mGluR group III) agonist | 0.132 0.006 CID_215925 | ||
| 0.178 | 0.011 | 0.178 | Rho-associated kinase I inhibitor | 0.148 0.014 CID_215925 | ||
| 0.201 | 0.034 | 0.201 | Vascular endothelial growth factor 2 antagonist | 0.151 0.049 CID_215925 | ||
| 0.186 | 0.022 | 0.186 | Beta amyloid protein antagonist | |||
| 0.169 | 0.007 | 0.169 | Histone deacetylase SIRT1 stimulant | 0.167 0.007 CID_215925 | ||
| 0.169 | 0.007 | 0.169 | Histone deacetylase stimulant | 0.167 0.007 CID_215925 | ||
| 0.202 | 0.04 | 0.202 | Lck kinase inhibitor | 0.117 0.087 CID_215925 | ||
| 0.172 | 0.011 | 0.172 | I kappa B kinase inhibitor | 0.105 0.035 CID_215925 | ||
| 0.201 | 0.041 | 0.201 | Vascular endothelial growth factor 3 antagonist | 0.196 0.043 CID_215925 | ||
| 0.192 | 0.033 | 0.192 | Glycogen synthase kinase-3 inhibitor | 0.127 0.057 CID_215925 | ||
| 0.179 | 0.02 | 0.179 | MAP kinase 8 inhibitor | 0.138 0.034 CID_215925 | ||
| 0.185 | 0.026 | 0.209 | Cyclin-dependent kinase 5 inhibitor | 0.209 0.02 CID_215925 | CID_215925 | |
| 0.184 | 0.026 | 0.213 | Ferrochelatase inhibitor | 0.213 0.019 CID_215925 | CID_215925 | |
| 0.183 | 0.028 | 0.183 | MAP kinase 12 inhibitor | 0.135 0.054 CID_215925 | ||
| 0.182 | 0.026 | 0.182 | Granulocyte macrophage colony stimulating factor antagonist | 0.122 0.051 CID_215925 | ||
| 0.162 | 0.007 | 0.162 | Histone deacetylase inhibitor | 0.131 0.01 CID_215925 | ||
| 0.284 | 0.132 | 0.387 | Histamine release inhibitor | 0.387 0.082 CID_215925 | CID_215925 | |
| 0.238 | 0.088 | 0.269 | Interleukin agonist | 0.269 0.066 CID_215925 | CID_215925 | |
| 0.172 | 0.024 | 0.172 | Fibroblast growth factor 1 antagonist | 0.117 0.045 CID_215925 | ||
| 0.23 | 0.085 | 0.23 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.211 0.094 CID_215925 | ||
| 0.159 | 0.014 | 0.159 | Polo-like kinase-1 inhibitor | 0.148 0.017 CID_215925 | ||
| 0.156 | 0.011 | 0.156 | Potassium channel (Voltage-sensitive) activator | 0.152 0.012 CID_215925 | ||
| 0.183 | 0.04 | 0.183 | GABA C receptor rho-2 antagonist | |||
| 0.155 | 0.013 | 0.155 | Glutamate (mGluR group I) antagonist | 0.115 0.021 CID_215925 | ||
| 0.165 | 0.022 | 0.165 | Pim-1 kinase inhibitor | |||
| 0.146 | 0.004 | 0.146 | 5 Hydroxytryptamine 1F agonist | 0.098 0.004 CID_215925 | ||
| 0.165 | 0.022 | 0.165 | Heat shock protein 70 antagonist | 0.164 0.023 CID_215925 | ||
| 0.165 | 0.023 | 0.165 | Insulin receptor antagonist | 0.107 0.053 CID_215925 | ||
| 0.191 | 0.049 | 0.191 | Protein-tyrosine kinase Lyn inhibitor | 0.109 0.094 CID_215925 | ||
| 0.182 | 0.041 | 0.182 | Hemostatic | 0.173 0.047 CID_215925 | ||
| 0.176 | 0.038 | 0.176 | Aurora-B kinase inhibitor | 0.159 0.043 CID_215925 | ||
| 0.162 | 0.025 | 0.162 | Protein kinase C gamma inhibitor | 0.105 0.068 CID_215925 | ||
| 0.142 | 0.008 | 0.142 | Bruton tyrosine kinase inhibitor | 0.096 0.016 CID_215925 | ||
| 0.163 | 0.03 | 0.163 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.142 0.035 CID_215925 | ||
| 0.193 | 0.061 | 0.193 | Lipocortins synthesis antagonist | |||
| 0.15 | 0.019 | 0.15 | MAP kinase 14 inhibitor | 0.121 0.027 CID_215925 | ||
| 0.148 | 0.018 | 0.148 | Acetylcholine release stimulant | 0.121 0.047 CID_215925 | ||
| 0.224 | 0.097 | 0.224 | DNA damaging | 0.161 0.156 CID_215925 | ||
| 0.21 | 0.084 | 0.21 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.163 | 0.038 | 0.163 | Glycogen synthase kinase-3 beta inhibitor | 0.118 0.063 CID_215925 | ||
| 0.166 | 0.041 | 0.166 | Glutamate receptor antagonist | |||
| 0.143 | 0.019 | 0.143 | Glutamate (mGluR) antagonist | 0.091 0.041 CID_215925 | ||
| 0.182 | 0.058 | 0.182 | MAP kinase kinase 5 inhibitor | 0.16 0.117 CID_215925 | ||
| 0.145 | 0.021 | 0.179 | Stem cell growth factor agonist | 0.179 0.013 CID_215925 | CID_215925 | |
| 0.148 | 0.026 | 0.148 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.144 | 0.024 | 0.144 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.116 0.035 CID_215925 | ||
| 0.166 | 0.047 | 0.166 | MAP kinase 3 inhibitor | 0.161 0.053 CID_215925 | ||
| 0.122 | 0.004 | 0.122 | Glutamate (mGluR4) agonist | 0.068 0.007 CID_215925 | ||
| 0.131 | 0.013 | 0.131 | CDC7 inhibitor | 0.087 0.031 CID_215925 | ||
| 0.169 | 0.052 | 0.169 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.103 0.098 CID_215925 | ||
| 0.138 | 0.022 | 0.138 | Rho-associated kinase inhibitor | 0.112 0.03 CID_215925 | ||
| 0.145 | 0.029 | 0.145 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.131 0.035 CID_215925 | ||
| 0.122 | 0.007 | 0.122 | Glutamate (mGluR5) antagonist | 0.098 0.01 CID_215925 | ||
| 0.129 | 0.015 | 0.135 | Adenosine A3 receptor antagonist | 0.135 0.014 CID_215925 | CID_215925 | |
| 0.153 | 0.04 | 0.19 | Protein kinase (CK2) alpha inhibitor | 0.19 0.026 CID_215925 | CID_215925 | |
| 0.148 | 0.035 | 0.148 | Interleukin 8 antagonist | 0.102 0.092 CID_215925 | ||
| 0.122 | 0.01 | 0.122 | Pim-2 kinase inhibitor | |||
| 0.15 | 0.039 | 0.17 | Death-associated protein kinase 1 inhibitor | 0.17 0.019 CID_215925 | CID_215925 | |
| 0.179 | 0.068 | 0.179 | Tumour necrosis factor antagonist | |||
| 0.131 | 0.021 | 0.131 | MAP-kinase-activated kinase inhibitor | 0.081 0.061 CID_215925 | ||
| 0.117 | 0.009 | 0.117 | I kappa B kinase 2 inhibitor | 0.073 0.028 CID_215925 | ||
| 0.198 | 0.089 | 0.217 | EphB2 antagonist | 0.217 0.076 CID_215925 | CID_215925 | |
| 0.162 | 0.057 | 0.162 | CF transmembrane conductance regulator agonist | 0.138 0.1 CID_215925 | ||
| 0.191 | 0.085 | 0.191 | Neurotrophic factor enhancer | |||
| 0.165 | 0.059 | 0.165 | CDC-like kinase 1 inhibitor | 0.117 0.098 CID_215925 | ||
| 0.234 | 0.128 | 0.234 | Immunomodulator | |||
| 0.156 | 0.052 | 0.156 | Toll-Like receptor antagonist | |||
| 0.131 | 0.029 | 0.131 | Hepatocyte growth factor antagonist | 0.108 0.044 CID_215925 | ||
| 0.116 | 0.015 | 0.116 | MAP kinase kinase 10 inhibitor | 0.106 0.017 CID_215925 | ||
| 0.137 | 0.037 | 0.169 | CDK3/cyclin E inhibitor | 0.169 0.016 CID_215925 | CID_215925 | |
| 0.137 | 0.037 | 0.137 | Check point kinase 2 inhibitor | |||
| 0.117 | 0.017 | 0.117 | Protein kinase C alpha inhibitor | 0.076 0.037 CID_215925 | ||
| 0.209 | 0.11 | 0.209 | DNA synthesis inhibitor | |||
| 0.127 | 0.029 | 0.127 | MAP kinase kinase 1 inhibitor | 0.085 0.078 CID_215925 | ||
| 0.14 | 0.042 | 0.14 | Cyclin-dependent kinase 2 inhibitor | 0.113 0.058 CID_215925 | ||
| 0.124 | 0.027 | 0.124 | Histamine N-methyltransferase inhibitor | |||
| 0.117 | 0.021 | 0.117 | MAP-kinase-activated kinase 2 inhibitor | 0.069 0.059 CID_215925 | ||
| 0.129 | 0.033 | 0.133 | Hedgehog signaling inhibitor | 0.133 0.031 CID_215925 | CID_215925 | |
| 0.11 | 0.014 | 0.11 | Secretase beta inhibitor | 0.104 0.016 CID_215925 | ||
| 0.115 | 0.02 | 0.115 | Cyclin A2 inhibitor | 0.072 0.037 CID_215925 | ||
| 0.131 | 0.035 | 0.131 | CDK2/cyclin A inhibitor | 0.1 0.058 CID_215925 | ||
| 0.148 | 0.054 | 0.148 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.124 | 0.03 | 0.156 | Potassium channel activator | 0.156 0.018 CID_215925 | CID_215925 | |
| 0.113 | 0.019 | 0.113 | Cyclin A inhibitor | 0.08 0.031 CID_215925 | ||
| 0.1 | 0.008 | 0.1 | Histone deacetylase class I inhibitor | 0.07 0.012 CID_215925 | ||
| 0.183 | 0.091 | 0.183 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.148 0.137 CID_215925 | ||
| 0.146 | 0.055 | 0.164 | Aurora-C kinase inhibitor | 0.164 0.036 CID_215925 | CID_215925 | |
| 0.122 | 0.031 | 0.122 | Protein kinase C zeta inhibitor | |||
| 0.099 | 0.008 | 0.099 | Cyclin A1 inhibitor | 0.088 0.011 CID_215925 | ||
| 0.149 | 0.059 | 0.149 | Sodium channel blocker | |||
| 0.116 | 0.026 | 0.116 | MAP kinase 10 inhibitor | 0.095 0.038 CID_215925 | ||
| 0.121 | 0.03 | 0.121 | TIE antagonist | 0.083 0.057 CID_215925 | ||
| 0.156 | 0.066 | 0.175 | NOS3 expression enhancer | 0.175 0.053 CID_215925 | CID_215925 | |
| 0.119 | 0.03 | 0.119 | TIE-2 antagonist | 0.078 0.059 CID_215925 | ||
| 0.101 | 0.013 | 0.101 | Aryl hydrocarbon receptor antagonist | 0.084 0.023 CID_215925 | ||
| 0.101 | 0.013 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.069 0.064 CID_215925 | ||
| 0.124 | 0.036 | 0.124 | GABA C receptor rho-1 antagonist | |||
| 0.124 | 0.036 | 0.124 | Nitric-oxide synthase inhibitor | |||
| 0.1 | 0.014 | 0.1 | Factor Xa inhibitor | 0.084 0.017 CID_215925 | ||
| 0.128 | 0.044 | 0.14 | Protein kinase (CK2) inhibitor | 0.14 0.037 CID_215925 | CID_215925 | |
| 0.115 | 0.032 | 0.117 | ErbB-3 antagonist | 0.117 0.031 CID_215925 | CID_215925 | |
| 0.117 | 0.035 | 0.117 | Insulin growth factor antagonist | 0.079 0.068 CID_215925 | ||
| 0.092 | 0.012 | 0.092 | Toll-Like receptor 8 antagonist | |||
| 0.109 | 0.029 | 0.109 | p38 MAP kinase inhibitor | 0.08 0.04 CID_215925 | ||
| 0.155 | 0.076 | 0.155 | Anticoagulant | 0.139 0.09 CID_215925 | ||
| 0.115 | 0.036 | 0.137 | Glutamate (mGluR7) agonist | 0.137 0.017 CID_215925 | CID_215925 | |
| 0.266 | 0.188 | 0.266 | Calcium channel L-type activator | |||
| 0.082 | 0.004 | 0.093 | Calcium release-activated channel blocker | 0.093 0.004 CID_215925 | CID_215925 | |
| 0.106 | 0.029 | 0.106 | Rho-associated kinase II inhibitor | 0.094 0.035 CID_215925 | ||
| 0.103 | 0.027 | 0.114 | Nav1.8 sodium channel blocker | 0.114 0.023 CID_215925 | CID_215925 | |
| 0.079 | 0.003 | 0.08 | MAP3K5 inhibitor | 0.08 0.003 CID_215925 | CID_215925 | |
| 0.223 | 0.147 | 0.228 | Ca(v)3.3 blocker | 0.228 0.137 CID_215925 | CID_215925 | |
| 0.155 | 0.08 | 0.155 | Src kinase inhibitor | |||
| 0.147 | 0.071 | 0.147 | Growth factor antagonist | 0.122 0.09 CID_215925 | ||
| 0.088 | 0.013 | 0.088 | Botulinum neurotoxin type A inhibitor | 0.083 0.015 CID_215925 | ||
| 0.102 | 0.027 | 0.102 | D-Ala-D-Ala ligase inhibitor | |||
| 0.104 | 0.03 | 0.104 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.09 | 0.015 | 0.09 | Protein kinase C epsilon inhibitor | 0.063 0.028 CID_215925 | ||
| 0.105 | 0.03 | 0.106 | Raf kinase inhibitor | 0.106 0.03 CID_215925 | CID_215925 | |
| 0.08 | 0.006 | 0.08 | Immunoglobulin Fc receptor antagonist | 0.065 0.016 CID_215925 | ||
| 0.114 | 0.041 | 0.114 | Protein kinase C delta inhibitor | |||
| 0.116 | 0.043 | 0.116 | CDK/cyclin complex inhibitor | 0.088 0.061 CID_215925 | ||
| 0.108 | 0.036 | 0.108 | Insulin like growth factor 1 antagonist | 0.077 0.065 CID_215925 | ||
| 0.148 | 0.077 | 0.148 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.085 | 0.014 | 0.085 | Cyclin D1 inhibitor | 0.077 0.021 CID_215925 | ||
| 0.099 | 0.028 | 0.099 | Tyk2 inhibitor | 0.08 0.037 CID_215925 | ||
| 0.123 | 0.053 | 0.123 | Aurora-A kinase inhibitor | 0.103 0.064 CID_215925 | ||
| 0.121 | 0.051 | 0.121 | Activin receptor-like kinase 4 inhibitor | 0.118 0.055 CID_215925 | ||
| 0.076 | 0.007 | 0.076 | Dihydropteroate synthase inhibitor | 0.044 0.022 CID_215925 | ||
| 0.072 | 0.004 | 0.086 | Hexokinase stimulant | 0.086 0.004 CID_215925 | CID_215925 | |
| 0.075 | 0.01 | 0.075 | Glutamate (mGluR1a) antagonist | |||
| 0.088 | 0.023 | 0.088 | CDK9/cyclin T1 inhibitor | 0.062 0.037 CID_215925 | ||
| 0.098 | 0.034 | 0.098 | Fibroblast growth factor 3 antagonist | 0.073 0.061 CID_215925 | ||
| 0.1 | 0.035 | 0.1 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.072 0.064 CID_215925 | ||
| 0.07 | 0.006 | 0.07 | Protein kinase (CK1) epsilon inhibitor | 0.038 0.029 CID_215925 | ||
| 0.116 | 0.052 | 0.116 | GABA C receptor agonist | |||
| 0.12 | 0.056 | 0.12 | 5 Hydroxytryptamine 3A agonist | |||
| 0.07 | 0.007 | 0.073 | Potassium channel KCNQ activator | 0.073 0.006 CID_215925 | CID_215925 | |
| 0.07 | 0.007 | 0.073 | Delayed rectifier potassium channel activator | 0.073 0.006 CID_215925 | CID_215925 | |
| 0.092 | 0.029 | 0.092 | Adenosine A2 receptor antagonist | 0.055 0.054 CID_215925 | ||
| 0.131 | 0.068 | 0.131 | CC chemokine 6 receptor antagonist | 0.126 0.088 CID_215925 | ||
| 0.075 | 0.013 | 0.087 | Stearoyl-CoA desaturase inhibitor | 0.087 0.01 CID_215925 | CID_215925 | |
| 0.077 | 0.015 | 0.084 | Adenosine A2b receptor antagonist | 0.084 0.013 CID_215925 | CID_215925 | |
| 0.219 | 0.158 | 0.263 | Interleukin 2 agonist | 0.263 0.105 CID_215925 | CID_215925 | |
| 0.104 | 0.043 | 0.104 | Protein kinase A inhibitor | 0.076 0.064 CID_215925 | ||
| 0.077 | 0.017 | 0.077 | MAP kinase kinase 9 inhibitor | 0.067 0.024 CID_215925 | ||
| 0.148 | 0.088 | 0.148 | Heat shock protein 90 alpha antagonist | 0.132 0.109 CID_215925 | ||
| 0.131 | 0.071 | 0.131 | RET inhibitor | |||
| 0.074 | 0.014 | 0.083 | Dihydroorotate oxidase inhibitor | 0.083 0.009 CID_215925 | CID_215925 | |
| 0.093 | 0.033 | 0.093 | T cell inhibitor | |||
| 0.092 | 0.033 | 0.092 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.071 0.051 CID_215925 | ||
| 0.085 | 0.027 | 0.085 | Raf kinase B inhibitor | 0.084 0.027 CID_215925 | ||
| 0.073 | 0.015 | 0.073 | Factor X inhibitor | 0.048 0.023 CID_215925 | ||
| 0.098 | 0.041 | 0.098 | AXL receptor tyrosine kinase inhibitor | |||
| 0.072 | 0.017 | 0.072 | Epithelial sodium channel blocker | |||
| 0.065 | 0.01 | 0.065 | Geranyltranstransferase inhibitor | 0.046 0.028 CID_215925 | ||
| 0.113 | 0.059 | 0.156 | Falcipain 3 inhibitor | 0.156 0.034 CID_215925 | CID_215925 | |
| 0.068 | 0.013 | 0.068 | Adenylate cyclase 1 inhibitor | |||
| 0.08 | 0.025 | 0.08 | Tyrosine-protein kinase EMT inhibitor | 0.057 0.04 CID_215925 | ||
| 0.123 | 0.069 | 0.123 | TRKB antagonist | |||
| 0.09 | 0.036 | 0.096 | 5 Hydroxytryptamine 1F antagonist | 0.096 0.033 CID_215925 | CID_215925 | |
| 0.07 | 0.016 | 0.07 | Glutamate (mGluR group I) agonist | 0.057 0.025 CID_215925 | ||
| 0.117 | 0.064 | 0.117 | Interleukin 1b antagonist | 0.108 0.073 CID_215925 | ||
| 0.151 | 0.099 | 0.19 | ATPase inhibitor | 0.19 0.046 CID_215925 | CID_215925 | |
| 0.078 | 0.026 | 0.078 | Purinergic P2X1 antagonist | |||
| 0.066 | 0.015 | 0.066 | Sodium/calcium exchanger inhibitor | |||
| 0.066 | 0.015 | 0.066 | Glutamate (mGluR5) agonist | 0.055 0.021 CID_215925 | ||
| 0.124 | 0.073 | 0.149 | Papain-like protease (SARS coronavirus) inhibitor | 0.149 0.035 CID_215925 | CID_215925 | |
| 0.055 | 0.005 | 0.065 | Methionyl aminopeptidase 1 inhibitor | 0.065 0.005 CID_215925 | CID_215925 | |
| 0.085 | 0.034 | 0.085 | MAP3K7 inhibitor | 0.074 0.049 CID_215925 | ||
| 0.065 | 0.015 | 0.065 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.071 | 0.02 | 0.071 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.051 0.031 CID_215925 | ||
| 0.089 | 0.039 | 0.091 | Protein kinase B gamma inhibitor | 0.091 0.038 CID_215925 | CID_215925 | |
| 0.093 | 0.045 | 0.093 | Platelet growth factor antagonist | 0.075 0.062 CID_215925 | ||
| 0.091 | 0.044 | 0.091 | Glutamate receptor agonist | |||
| 0.073 | 0.025 | 0.082 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.082 0.018 CID_215925 | CID_215925 | |
| 0.078 | 0.03 | 0.078 | Potassium channel (ATP-sensitive) blocker | 0.071 0.04 CID_215925 | ||
| 0.137 | 0.091 | 0.137 | MAP kinase kinase 4 inhibitor | |||
| 0.06 | 0.015 | 0.077 | CDK5/p25 inhibitor | 0.077 0.009 CID_215925 | CID_215925 | |
| 0.199 | 0.154 | 0.199 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.084 | 0.042 | 0.109 | Histone deacetylase SIRT2 inhibitor | 0.109 0.022 CID_215925 | CID_215925 | |
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR4) antagonist | |||
| 0.077 | 0.035 | 0.077 | Protein kinase C beta inhibitor | |||
| 0.099 | 0.057 | 0.099 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.085 | 0.044 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.106 | 0.065 | 0.114 | CDC-like kinase 3 inhibitor | 0.114 0.052 CID_215925 | CID_215925 | |
| 0.103 | 0.063 | 0.103 | Carbonic anhydrase XV inhibitor | |||
| 0.108 | 0.068 | 0.108 | Polo-like kinase-4 inhibitor | |||
| 0.069 | 0.029 | 0.093 | Histone deacetylase SIRT3 inhibitor | 0.093 0.012 CID_215925 | CID_215925 | |
| 0.061 | 0.021 | 0.061 | Topoisomerase II beta inhibitor | 0.054 0.027 CID_215925 | ||
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic agonist | 0.075 0.063 CID_215925 | ||
| 0.089 | 0.05 | 0.089 | Myeloperoxidase inhibitor | |||
| 0.046 | 0.009 | 0.046 | ATR kinase inhibitor | 0.031 0.028 CID_215925 | ||
| 0.081 | 0.044 | 0.081 | MAP kinase kinase 7 inhibitor | |||
| 0.106 | 0.069 | 0.106 | GABA C receptor antagonist | |||
| 0.068 | 0.031 | 0.068 | Corticotropin releasing factor 2 receptor antagonist | 0.063 0.04 CID_215925 | ||
| 0.066 | 0.029 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.117 | 0.08 | 0.117 | Cathepsin H inhibitor | |||
| 0.054 | 0.02 | 0.054 | Cytokine production stimulant | 0.048 0.036 CID_215925 | ||
| 0.043 | 0.01 | 0.043 | Protein kinase (CK2) beta inhibitor | 0.034 0.021 CID_215925 | ||
| 0.05 | 0.018 | 0.05 | Histamine H1 receptor agonist | 0.041 0.037 CID_215925 | ||
| 0.047 | 0.015 | 0.052 | DNA gyrase subunit B inhibitor | 0.052 0.012 CID_215925 | CID_215925 | |
| 0.06 | 0.028 | 0.06 | Lysine-specific demethylase 1A inhibitor | |||
| 0.086 | 0.055 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.079 | 0.048 | 0.195 | Vanilloid antagonist | 0.195 0.014 CID_215925 | CID_215925 | |
| 0.059 | 0.028 | 0.059 | Urokinase inhibitor | |||
| 0.075 | 0.044 | 0.075 | Syk tyrosine kinase inhibitor | |||
| 0.11 | 0.079 | 0.146 | Histone deacetylase class III inhibitor | 0.146 0.047 CID_215925 | CID_215925 | |
| 0.098 | 0.068 | 0.098 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.071 | 0.041 | 0.071 | Cyclin-dependent kinase 4 inhibitor | 0.065 0.046 CID_215925 | ||
| 0.092 | 0.062 | 0.092 | Potassium channel (Ca-activated) activator | |||
| 0.107 | 0.078 | 0.107 | Adenylate cyclase inhibitor | |||
| 0.04 | 0.01 | 0.04 | CDK4/cyclin D3 inhibitor | |||
| 0.065 | 0.036 | 0.065 | Adenosine A1 receptor antagonist | |||
| 0.063 | 0.035 | 0.063 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.071 | 0.112 | Mediator release inhibitor | 0.112 0.056 CID_215925 | CID_215925 | |
| 0.064 | 0.037 | 0.064 | Protein kinase C iota inhibitor | |||
| 0.044 | 0.018 | 0.044 | Potassium channel Kv1.1 blocker | 0.043 0.019 CID_215925 | ||
| 0.071 | 0.045 | 0.071 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.091 | 0.067 | 0.091 | Platelet activating factor alpha antagonist | 0.086 0.073 CID_215925 | ||
| 0.071 | 0.047 | 0.071 | CDK2/cyclin E2 inhibitor | 0.062 0.059 CID_215925 | ||
| 0.033 | 0.009 | 0.034 | Glucosylceramidase stimulant | 0.034 0.007 CID_215925 | CID_215925 | |
| 0.197 | 0.173 | 0.197 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.07 | 0.047 | 0.07 | CDK1/cyclin B1 inhibitor | |||
| 0.143 | 0.121 | 0.143 | Phospholipase C inhibitor | |||
| 0.028 | 0.006 | 0.028 | Cyclin T1 inhibitor | |||
| 0.061 | 0.04 | 0.061 | Cyclin-dependent kinase 6 inhibitor | 0.059 0.042 CID_215925 | ||
| 0.027 | 0.006 | 0.027 | Factor XIII inhibitor | 0.026 0.006 CID_215925 | ||
| 0.053 | 0.033 | 0.053 | Diacylglycerol O-acyltransferase inhibitor | 0.045 0.044 CID_215925 | ||
| 0.099 | 0.079 | 0.099 | Platelet activating factor antagonist | |||
| 0.143 | 0.123 | 0.221 | Death-associated protein kinase 2 inhibitor | 0.221 0.023 CID_215925 | CID_215925 | |
| 0.073 | 0.054 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 CID_215925 | CID_215925 | |
| 0.045 | 0.026 | 0.045 | Dihydrofolate reductase inhibitor | |||
| 0.068 | 0.049 | 0.068 | Exportin-1 inhibitor | |||
| 0.051 | 0.033 | 0.061 | Transforming growth factor beta 1 antagonist | 0.061 0.025 CID_215925 | CID_215925 | |
| 0.033 | 0.014 | 0.033 | Histone deacetylase 1 inhibitor | |||
| 0.048 | 0.03 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.088 | 0.07 | 0.088 | Protein kinase C mu inhibitor | |||
| 0.061 | 0.043 | 0.061 | Adenosine A2a receptor antagonist | |||
| 0.023 | 0.005 | 0.023 | Complement factor D inhibitor | 0.018 0.014 CID_215925 | ||
| 0.058 | 0.041 | 0.058 | Cyclin H inhibitor | |||
| 0.052 | 0.035 | 0.057 | Factor IXa inhibitor | 0.057 0.029 CID_215925 | CID_215925 | |
| 0.156 | 0.14 | 0.156 | Antiamyloidogenic | |||
| 0.068 | 0.051 | 0.068 | I kappa B kinase 1 inhibitor | |||
| 0.088 | 0.072 | 0.088 | Platelet activating factor beta antagonist | |||
| 0.044 | 0.03 | 0.044 | AICAR transformylase inhibitor | |||
| 0.091 | 0.077 | 0.091 | Gastric antisecretory | 0.086 0.084 CID_215925 | ||
| 0.024 | 0.01 | 0.038 | Apolipoprotein B inhibitor | 0.038 0.005 CID_215925 | CID_215925 | |
| 0.057 | 0.044 | 0.057 | Biliverdin reductase inhibitor | |||
| 0.072 | 0.058 | 0.072 | GABA aminotransferase inhibitor | |||
| 0.037 | 0.025 | 0.037 | Integrin alpha2 antagonist | |||
| 0.052 | 0.039 | 0.052 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 CID_215925 | ||
| 0.03 | 0.018 | 0.03 | MAP3K8 inhibitor | 0.027 0.026 CID_215925 | ||
| 0.095 | 0.084 | 0.095 | GABA receptor agonist | |||
| 0.012 | 0.001 | 0.012 | Reverse transcriptase (HBV) inhibitor | 0.007 0.002 CID_215925 | ||
| 0.044 | 0.034 | 0.044 | Phosphorylase inhibitor | |||
| 0.068 | 0.058 | 0.068 | Porphobilinogen synthase inhibitor | |||
| 0.051 | 0.041 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Purinergic P2Y15 antagonist | |||
| 0.055 | 0.045 | 0.055 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.061 | 0.052 | 0.061 | Transcription factor RelA inhibitor | |||
| 0.077 | 0.068 | 0.077 | Inducible nitric-oxide synthase inhibitor | |||
| 0.059 | 0.05 | 0.07 | 5 Hydroxytryptamine 1D antagonist | 0.07 0.038 CID_215925 | CID_215925 | |
| 0.018 | 0.008 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.069 | 0.06 | 0.071 | Orexin receptor 1 antagonist | 0.071 0.052 CID_215925 | CID_215925 | |
| 0.181 | 0.173 | 0.181 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.042 | 0.034 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.058 | 0.051 | 0.058 | DNA gyrase inhibitor | |||
| 0.061 | 0.054 | 0.061 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.08 | 0.073 | 0.081 | Hematopoietic | 0.081 0.069 CID_215925 | CID_215925 | |
| 0.121 | 0.115 | 0.121 | Thiol protease inhibitor | 0.12 0.118 CID_215925 | ||
| 0.038 | 0.033 | 0.06 | Smo receptor antagonist | 0.06 0.019 CID_215925 | CID_215925 | |
| 0.052 | 0.047 | 0.052 | Kallikrein 1 inhibitor | |||
| 0.053 | 0.049 | 0.053 | CDK4/cyclin D inhibitor | |||
| 0.035 | 0.03 | 0.035 | Factor VIIa inhibitor | |||
| 0.097 | 0.092 | 0.097 | c-Src kinase inhibitor | |||
| 0.025 | 0.021 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.038 | 0.033 | 0.038 | Integrin alpha5beta1 antagonist | |||
| 0.047 | 0.043 | 0.047 | Aconitate hydratase inhibitor | |||
| 0.039 | 0.035 | 0.039 | Histamine H2 receptor agonist | |||
| 0.02 | 0.016 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.034 | 0.03 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.081 | 0.078 | 0.081 | Breast cancer-resistant protein inhibitor | |||
| 0.085 | 0.081 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.1 0.058 CID_215925 | CID_215925 | |
| 0.048 | 0.046 | 0.052 | Nicotinic alpha7 receptor agonist | 0.052 0.04 CID_215925 | CID_215925 | |
| 0.091 | 0.088 | 0.091 | Cystathionine beta-synthase inhibitor | |||
| 0.075 | 0.073 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.062 | 0.06 | 0.062 | MAP kinase kinase 8 inhibitor | 0.062 0.06 CID_215925 | ||
| 0.06 | 0.059 | 0.06 | HIV-1 reverse transcriptase inhibitor | |||
| 0.073 | 0.072 | 0.099 | Neuropeptide Y antagonist | 0.099 0.041 CID_215925 | CID_215925 | |
| 0.036 | 0.034 | 0.042 | Histone deacetylase 9 inhibitor | 0.042 0.023 CID_215925 | CID_215925 | |
| 0.163 | 0.162 | 0.187 | 5 Hydroxytryptamine 3E antagonist | 0.187 0.087 CID_215925 | CID_215925 | |
| 0.038 | 0.037 | 0.038 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.066 | 0.065 | 0.066 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.006 | 0.005 | 0.006 | CC chemokine 6 receptor agonist | |||
| 0.085 | 0.085 | 0.091 | Interleukin 12 antagonist | 0.091 0.071 CID_215925 | CID_215925 | |
| 0.016 | 0.016 | 0.029 | Apolipoprotein B-100 inhibitor | 0.029 0.006 CID_215925 | CID_215925 | |
| 0.041 | 0.042 | 0.054 | Chemokine receptor agonist | 0.054 0.032 CID_215925 | CID_215925 | |
| 0.01 | 0.011 | 0.011 | Thrombopoietin agonist | 0.011 0.009 CID_215925 | CID_215925 | |
| 0.049 | 0.051 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.044 CID_215925 | CID_215925 | |
| 0.011 | 0.016 | 0.015 | Microsomal triglyceride transfer protein inhibitor | 0.015 0.01 CID_215925 | CID_215925 | |
| 0.081 | 0.086 | 0.083 | Sphingomyelinase inhibitor | 0.083 0.082 CID_215925 | CID_215925 | |
| 0.038 | 0.043 | 0.061 | Dihydroorotase inhibitor | 0.061 0.016 CID_215925 | CID_215925 | |
| 0.021 | 0.028 | 0.028 | Nicotinamide phosphoribosyltransferase inhibitor | 0.028 0.02 CID_215925 | CID_215925 | |
| 0.021 | 0.029 | 0.026 | Cyclin E2 inhibitor | 0.026 0.022 CID_215925 | CID_215925 | |
| 0.094 | 0.105 | 0.122 | Nav1.3 sodium channel blocker | 0.122 0.071 CID_215925 | CID_215925 | |
| 0.043 | 0.056 | 0.049 | Alcohol oxidase inhibitor | 0.049 0.047 CID_215925 | CID_215925 | |
| 0.052 | 0.068 | 0.076 | Vanilloid 1 antagonist | 0.076 0.039 CID_215925 | CID_215925 | |
| 0.008 | 0.028 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 CID_215925 | CID_215925 | |
| 0.044 | 0.063 | 0.059 | Heparanase inhibitor | 0.059 0.024 CID_215925 | CID_215925 | |
| 0.026 | 0.046 | 0.034 | Histone deacetylase 7 inhibitor | 0.034 0.029 CID_215925 | CID_215925 | |
| 0.097 | 0.117 | 0.104 | Transcription factor STAT6 inhibitor | 0.104 0.096 CID_215925 | CID_215925 | |
| 0.093 | 0.113 | 0.182 | Alpha-N-acetylglucosaminidase inhibitor | 0.182 0.04 CID_215925 | CID_215925 | |
| 0.072 | 0.099 | 0.081 | Bromodomain-containing protein 2 inhibitor | 0.081 0.076 CID_215925 | CID_215925 | |
| 0.053 | 0.081 | 0.093 | Amidase inhibitor | 0.093 0.028 CID_215925 | CID_215925 | |
| 0.036 | 0.065 | 0.056 | Cyclin E inhibitor | 0.056 0.043 CID_215925 | CID_215925 | |
| 0.024 | 0.052 | 0.033 | Carnitine palmitoyltransferase 1 inhibitor | 0.033 0.026 CID_215925 | CID_215925 | |
| 0.02 | 0.051 | 0.03 | Cyclophilin A inhibitor | 0.03 0.022 CID_215925 | CID_215925 | |
| 0.013 | 0.046 | 0.02 | Potassium channel (Inward rectifier) 11 blocker | 0.02 0.009 CID_215925 | CID_215925 | |
| 0.052 | 0.086 | 0.069 | ErbB-4 antagonist | 0.069 0.061 CID_215925 | CID_215925 | |
| 0.022 | 0.057 | 0.032 | Carnitine palmitoyltransferase inhibitor | 0.032 0.027 CID_215925 | CID_215925 | |
| 0.032 | 0.07 | 0.055 | Dihydroorotate dehydrogenase inhibitor | 0.055 0.032 CID_215925 | CID_215925 | |
| 0.118 | 0.155 | 0.227 | Interleukin antagonist | 0.227 0.071 CID_215925 | CID_215925 | |
| 0.022 | 0.06 | 0.035 | Diamine oxidase inhibitor | 0.035 0.03 CID_215925 | CID_215925 | |
| 0.119 | 0.171 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | 0.173 0.071 CID_215925 | CID_215925 | |
| 0.018 | 0.07 | 0.029 | Epoxide hydrolase 1 inhibitor | 0.029 0.025 CID_215925 | CID_215925 | |
| 0.091 | 0.147 | 0.147 | Cytidine deaminase inhibitor | 0.147 0.077 CID_215925 | CID_215925 | |
| 0.081 | 0.139 | 0.141 | Cyclooxygenase 3 inhibitor | 0.141 0.056 CID_215925 | CID_215925 | |
| 0.155 | 0.218 | 0.198 | Neuropeptide Y2 antagonist | 0.198 0.122 CID_215925 | CID_215925 | |
| 0.046 | 0.112 | 0.066 | Epoxide hydrolase inhibitor | 0.066 0.06 CID_215925 | CID_215925 | |
| 0.179 | 0.245 | 0.264 | DNA directed DNA polymerase inhibitor | 0.264 0.183 CID_215925 | CID_215925 | |
| 0.177 | 0.243 | 0.297 | DNA polymerase beta inhibitor | 0.297 0.167 CID_215925 | CID_215925 | |
| 0.078 | 0.171 | 0.121 | Interleukin 4 antagonist | 0.121 0.083 CID_215925 | CID_215925 | |
| 0.147 | 0.246 | 0.254 | Transcription factor STAT inhibitor | 0.254 0.084 CID_215925 | CID_215925 | |
| 0.146 | 0.247 | 0.299 | Calpain 2 inhibitor | 0.299 0.115 CID_215925 | CID_215925 | |
| 0.069 | 0.172 | 0.115 | M17 leucyl aminopeptidase inhibitor | 0.115 0.082 CID_215925 | CID_215925 | |
| 0.076 | 0.179 | 0.12 | Histone deacetylase SIRT1 inhibitor | 0.12 0.091 CID_215925 | CID_215925 | |
| 0.135 | 0.239 | 0.247 | Transcription factor STAT3 inhibitor | 0.247 0.085 CID_215925 | CID_215925 | |
| 0.107 | 0.246 | 0.181 | Calpain inhibitor | 0.181 0.134 CID_215925 | CID_215925 | |
| 0.116 | 0.262 | 0.261 | Beta lactamase inhibitor | 0.261 0.152 CID_215925 | CID_215925 | |
| 0.054 | 0.213 | 0.103 | Caspase 3 inhibitor | 0.103 0.087 CID_215925 | CID_215925 | |
| 0.02 | 0.239 | 0.083 | Neuraminidase (influenza) inhibitor | 0.083 0.023 CID_215925 | CID_215925 | |
| 0.014 | 0.278 | 0.049 | Neuraminidase (Influenza A) inhibitor | 0.049 0.025 CID_215925 | CID_215925 | |
| 0.011 | 0.286 | 0.083 | Neuraminidase inhibitor | 0.083 0.023 CID_215925 | CID_215925 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |